We simplify insulin management for providers and patients.
We’re a trusted partner with the technology, services and clinical expertise to enable personalized insulin management across the continuum of care with inpatient and outpatient solutions. We reduce costs and improve patient outcomes by decreasing length of stay and readmissions, standardizing workflows, and nearly eliminating hypo and hyperglycemia events.
We Help Providers
We Help Patients
Reduction in Inpatient Hypoglycemia
Reduction in A1C
Reduction in 30-Day Readmissions
Reduction in Average Length of Stay
Patients Love Glytec!
“We realized within the first two weeks that I needed three times the insulin I was taking. This program is literally a lifesaver."
Type 1 Diabetes
“I like the instant feedback and that I don’t have to wait 3 or 4 months until my next doctor’s appointment to have my dose adjusted.”
Type 2 Diabetes
“I feel so much better. I no longer have frequent thirst or blurred vision. I am extremely pleased with my progress in this program.”
Type 2 Diabetes
What Do Our Clients Say?
“Glytec has demonstrated subject matter expertise in glycemic management, insulin therapy and workflow optimization. They’ve taken a highly collaborative and flexible approach, which we truly appreciate, and we’ve had great results. I can definitely say that Glytec’s system is helping us deliver proactive, personalized care, which is our top priority.”
A.J. Patefield, MD
Senior Vice President and Chief Medical Information Officer, Novant Health
“We collaborated with Glytec and immediately saw a significant improvement in glucose management. We are able to keep our patients within the defined parameters, they recover faster, have better outcomes, and fewer length of stay days. This is one of the best practices we have in our health system, and the evidence is there.”
Audrey Douglas-Cooke, RN, MS
Vice President Heart Hospital and former Vice President Patient Care Services, Sentara Healthcare
“Providing clinicians with actionable data for patient-specific insulin dosing has demonstrated a faster time to normalization. This initiative effectively aligned functional IT capabilities with the practical needs of clinicians.”
Brian Tew, CHCIO, CPHIMS
Vice President and CIO, Greater Hudson Valley Health System
“With nearly a third of hospitalized patients requiring insulin therapy during their stay, it is critical to focus significant attention on this very important aspect of care. As we continue to leverage best practices and innovation through our partnership with Glytec, we will increasingly improve care quality and outcomes, especially for the many patients with diabetes.”
J. Michael Yurso, MD
Vice President of Clinical Reliability, AdventHealth
“A measure advance in the treatment of inpatient hyperglycemia has been the development of computer-guided algorithms for insulin dosing; also, alerts to help the nurses stay on top of glycemic indicators and blood glucose checks. We use the Glytec system with Glucommander™ to help facilitate hyperglycemic management and adjust insulin dosing according to the many changes that happen in the ICU, in a safe way.”
Guillermo Umpierrez, MD, CDE, FACP, FACE
Chief of Diabetes and Endocrinology, Grady Hospital
“Glycemic management has always been a major priority for our health system, and our results have historically been excellent versus the national averages, yet even with a strong program centered on standard protocols, we are always seeking to achieve higher standards of care. eGMS® is a purpose-built system that mitigates gaps in care and pairs best practices in glycemic management with leading EHR technology.”
Mikhail Kosiborod, MD, FACC, FAHA
Cardiologist and Clinical Scholar, Saint Luke’s Health System, Mid America Heart Institute
“Diabetes management in the hospital is not a set-it-and-forget-it strategy, it needs to be personalized. It is perhaps the ultimate in a patient-centered approach. Across the institutions where the eGlycemic Management System® has been implemented, decreases in rates of severe hypoglycemia are on the order of 40 to 95 percent. That’s substantial!”
Richard Pratley, MD
Associate Medical Director of Research and Education, AdventHealth Diabetes Institute
Learn how Sentara Healthcare standardized glycemic management across 14 hospitals and virtually eliminated hypoglycemic events.
Ready to take insulin management to the next level?
What's wrong with the insulin management status quo? Find out in our Executive Brief.
Improved Patient Safety and Glycemic Outcomes in the ICU Using Computer-Guided Intravenous Insulin Therapy Versus Subcutaneous Insulin Therapy.
COVID-19 Crisis: Why Now is the Time to Invest in Glycemic Management.
eGlycemic Management System Overview: See how Glytec is revolutionizing glycemic management and uniting teams around patient safety.
You’re in Good Company
Healthcare organizations nationwide partner with Glytec on solutions that drive best practices in insulin management and medication optimization. Here are just a few.